A glycation connection
Authors:
- Charles R. HarringtonCharles R. Harrington
- Camilo A. L. S. ColacoCCCamilo A. L. S. Colaco
- 1 July 1994
- journal article
- Published by Springer Nature in Nature
- Vol. 370 (6487) , 247-248
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- ALZHEIMER DISEASEAlzheimer Disease & Associated Disorders, 1995
- Advanced Maillard reaction end products are associated with Alzheimer disease pathology.Proceedings of the National Academy of Sciences, 1994
- Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failureThe Lancet, 1994
- Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer diseaseNature Genetics, 1994
- Amelioration of diabetic nephropathy by treatment with monoclonal antibodies against glycated albuminKidney International, 1994
- Advanced glycation end products contribute to amyloidosis in Alzheimer disease.Proceedings of the National Academy of Sciences, 1994
- Alzheimer's-disease-like changes in tau protein processing: association with aluminium accumulation in brains of renal dialysis patientsThe Lancet, 1994
- Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.Proceedings of the National Academy of Sciences, 1993
- Apolipoprotein E ∈4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseasesThe Lancet, 1993
- Amyloidogenicity of beta A4 and beta A4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation.Journal of Biological Chemistry, 1992